Breakdown | TTM | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 | Dec 2020 |
---|---|---|---|---|---|---|
Income Statement | ||||||
Total Revenue | 14.28B | 14.54B | 14.66B | 14.85B | 12.52B | 10.58B |
Gross Profit | 5.04B | 5.34B | 5.67B | 5.79B | 5.14B | 4.36B |
EBITDA | 6.72B | 7.07B | 7.34B | 7.39B | 6.65B | 5.76B |
Net Income | 3.24B | 3.47B | 3.71B | 4.17B | 3.78B | 2.77B |
Balance Sheet | ||||||
Total Assets | 43.20B | 42.76B | 42.41B | 41.91B | 40.53B | 39.79B |
Cash, Cash Equivalents and Short-Term Investments | 1.15B | 1.00B | 1.44B | 2.09B | 2.32B | 3.13B |
Total Debt | 19.61B | 18.99B | 19.09B | 18.05B | 16.37B | 16.70B |
Total Liabilities | 31.02B | 30.26B | 30.27B | 29.29B | 27.03B | 26.68B |
Stockholders Equity | 12.17B | 12.50B | 12.13B | 12.63B | 13.50B | 13.11B |
Cash Flow | ||||||
Free Cash Flow | 2.69B | 2.72B | 3.27B | 3.49B | 3.31B | 2.64B |
Operating Cash Flow | 5.42B | 5.25B | 5.55B | 5.62B | 5.10B | 4.26B |
Investing Cash Flow | -2.75B | -2.60B | -2.29B | -2.13B | -1.88B | -649.00M |
Financing Cash Flow | -3.01B | -3.06B | -3.87B | -3.77B | -4.11B | -1.44B |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
---|---|---|---|---|---|---|---|
78 Outperform | $57.54B | 17.43 | 24.52% | 2.12% | 0.70% | 135.08% | |
74 Outperform | $85.19B | 14.49 | 35.96% | 6.60% | 1.30% | -0.76% | |
73 Outperform | $61.03B | 19.36 | 26.13% | 1.60% | -2.39% | -7.80% | |
73 Outperform | $53.19B | 13.18 | 14.69% | 2.61% | 0.27% | ― | |
72 Outperform | $33.89B | 30.06 | 26.59% | 0.70% | -2.63% | -6.12% | |
69 Neutral | $14.16B | 25.92 | 13.97% | 1.23% | -3.82% | -12.80% | |
58 Neutral | $1.34B | 4.08 | -2.93% | 10.79% | 3.41% | -51.76% |
On May 7, 2025, CSX Corporation held its Annual Meeting of Shareholders where twelve directors were elected to the board. Additionally, shareholders ratified the appointment of Ernst & Young LLP as the independent registered public accounting firm for 2025 and approved, on a non-binding basis, the compensation of CSX’s named executive officers.
The most recent analyst rating on (CSX) stock is a Buy with a $39.00 price target. To see the full list of analyst forecasts on CSX stock, see the CSX Stock Forecast page.